Brief: Pasithea Therapeutics Says Co Received A Letter From Nasdaq Stating That It Regained Compliance With Minimum Bid Price Requirement
18/01/2024 23:22
Jan 18 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS CORP - ON JAN 17, RECEIVED A LETTER
FROM
NASDAQ STATING THAT CO REGAINED COMPLIANCE WITH MINIMUM BID
PRICE REQUIREMENT
Further company coverage: KTTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement